The pharmaceutical company stopped production of those drugs last may after a series of recalls. They are trying to replace that inventory.
Despite shipping a small amount last quarter, Johnson and Johnson now says it won't fully catch up until later this year.
Last quarter, sales of over the counter medicines fell 53 percent, costing the company about $300 million.